| Literature DB >> 31894599 |
Shuai Liu1, Jumin Yang1, Ruiwei Guo1, Liandong Deng1, Anjie Dong1, Jianhua Zhang1,2.
Abstract
Covalent organic frameworks (COFs) as drug delivery systems have shown great promise, but their pharmaceutical applications are often limited by complex building blocks, tedious preparations, irregular shape, and uncontrolled drug release within target cells. Herein, a facile strategy is developed to prepare PEGylated redox-responsive nanoscale COFs (denoted F68@SS-COFs) for efficiently loading and delivering doxorubicin (DOX) by use of FDA-approved Pluronic F68 and commercially available building blocks. The obtained F68@SS-COFs with controlled size, high stability, and good biocompatibility can not only achieve a very high DOX-loading content (about 21%) and very low premature leakage at physiological condition but can also rapidly respond to the tumor intracellular microenvironment and efficiently release DOX to kill tumor cells. Considering the readily available raw materials, simple preparation process, and desirable redox-responsiveness, the strategy provided here opens up a promising avenue to develop well-defined COFs-based nanomedicines for cancer therapy.Entities:
Keywords: covalent organic frameworks; doxorubicin; drug delivery; redox-sensitive nanocarriers
Mesh:
Substances:
Year: 2020 PMID: 31894599 DOI: 10.1002/marc.201900570
Source DB: PubMed Journal: Macromol Rapid Commun ISSN: 1022-1336 Impact factor: 5.734